These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9145459)

  • 1. Lactulose and renal failure.
    Vogt B; Frey FJ
    Scand J Gastroenterol Suppl; 1997; 222():100-1. PubMed ID: 9145459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: a multicentre study of bile salts and lactulose.
    Pain JA; Cahill CJ; Gilbert JM; Johnson CD; Trapnell JE; Bailey ME
    Br J Surg; 1991 Apr; 78(4):467-9. PubMed ID: 2032107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of postoperative complications in jaundiced rats. Internal biliary drainage versus oral lactulose.
    Greve JW; Maessen JG; Tiebosch T; Buurman WA; Gouma DJ
    Ann Surg; 1990 Aug; 212(2):221-7. PubMed ID: 2375652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental and clinical study of lactulose in obstructive jaundice.
    Pain JA; Bailey ME
    Br J Surg; 1986 Oct; 73(10):775-8. PubMed ID: 3768644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactulose for reduction of nitrogen products in patients with chronic kidney disease.
    Tayebi Khosroshahi H; Habibzadeh A; Khoshbaten M; Rahbari B; Chaichi P; Badiee AH
    Iran J Kidney Dis; 2014 Sep; 8(5):377-81. PubMed ID: 25194404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term effect of lactulose therapy in patients with chronic renal failure.
    Miura M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1989 Mar; 14(1):29-34. PubMed ID: 2699952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstructive jaundice. Renal failure and other endotoxin-related complications.
    Cahill CJ; Pain JA
    Surg Annu; 1988; 20():17-37. PubMed ID: 3283963
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal failure in obstructive jaundice.
    Uslu A; Cayci M; Nart A; Karaca C; Zalluhoglu N; Gürkan A; Varilsuha C; Adagülü H
    Hepatogastroenterology; 2005; 52(61):52-4. PubMed ID: 15782993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy.
    Neff GW; Kemmer N; Zacharias VC; Kaiser T; Duncan C; McHenry R; Jonas M; Novick D; Williamson C; Hess K; Thomas M; Buell J
    Transplant Proc; 2006 Dec; 38(10):3552-5. PubMed ID: 17175328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of lactulose in the treatment of chronic renal failure].
    Quarto di Palo F; Buccianti G; Civardi F
    Minerva Med; 1978 Feb; 69(7):455-60. PubMed ID: 634497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lactulose therapy for chronic renal failure].
    Miyazaki M; Aoyagi K; Tojo S
    Nihon Jinzo Gakkai Shi; 1984 Aug; 26(8):1091-8. PubMed ID: 6513180
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hepatic encephalopathy: it's not lactulose.
    Shawcross DL; Jalan R
    BMJ; 2004 Jul; 329(7457):112; author reply 112. PubMed ID: 15242927
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Agrawal A; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.
    Huang E; Esrailian E; Spiegel BM
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1147-61. PubMed ID: 17894657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic encephalopathy -- preventative effects of lactulose].
    Z Gastroenterol; 2013 Aug; 51(8):708. PubMed ID: 24298621
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
    Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
    Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice.
    Gubern JM; Sancho JJ; Simó J; Sitges-Serra A
    Surgery; 1988 Jan; 103(1):39-44. PubMed ID: 3122349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.